Theratechnologies (THTX) Soars 45.86% on Acquisition Talks, Buy Rating

Theratechnologies (THTX) shares surged 45.86% today, reaching their highest level since January 2024, with an intraday gain of 72.18%.

Theratechnologies is currently in exclusive discussions with a potential acquirer for the sale of the company. This development follows the company's rejection of acquisition proposals from Future Pak, citing inadequate terms. Despite the rejection, the company's shares experienced a significant increase after Future Pak disclosed two acquisition proposals. This news has sparked positive investor sentiment, contributing to the recent surge in Theratechnologies' stock price.

Adding to the positive outlook, Theratechnologies has been upgraded to a "Buy" rating by JonesResearch, with a price target set at $3. This rating upgrade reflects the analysts' confidence in the company's future prospects and has further bolstered investor optimism. The combination of potential acquisition and a favorable rating upgrade has created a bullish environment for Theratechnologies, driving its stock price to new heights.